Relation among the 2:2-, 1:1- and 1:2-type complexes of hafnium(IV)/zirconium(IV) with mono-lacunary α2-Dawson polyoxometalate ligands: Synthesis and structure of the 2:2-type complexes [{α2-P2W17O61M(μ-OH)(H2O)}2] (M = Hf, Zr)

The synthesis and characterization of di-nuclear Hf^IV and Zr^IV complexes (the Dawson 2:2-type complexes) sandwiched between 2 mono-lacunary α₂-Dawson polyoxometalate (POM) ligands, i.e., (Me₂NH₂)₁₄[{α₂-P₂W₁₇O₆₁Hf(μ-OH)(H₂O)}₂]·17H₂O (Me₂NH₂-1) and (Me₂NH₂)₁₄[{α₂-P₂W₁₇O₆₁Zr(μ-OH)(H₂O)}₂]·16H₂O (Me₂NH₂-2) are described. [Note: the moieties of their polyoxoanions are abbreviated simply as 1 and 2, respectively.] A pair of Hf^IV- and Zr^IV-containing POMs belonging to the same family were herein isolated as dimethylammonium salts and were unambiguously characterized by complete elemental analysis, in addition to potassium analysis, TG/DTA, FTIR, single-crystal X-ray structure analysis, and solid-state (³¹P CPMAS) and solution (³¹P and ¹⁸³W) NMR spectroscopy. Polyoxoanions 1 and 2 were isostructural with each other. The central [M₂(μ-OH)₂(H₂O)₂]⁶⁺ (M = Hf, Zr) cation unit was composed of 2 polyhedral M units, which were linked through 2 μ-OH groups and contained 1 water molecule coordinated to each metal center. Since the mono-lacunary Dawson POM acts as an oxygen-donor quadridentate ligand, the Hf and Zr centers are 7-coordinate. The Dawson 2:2-type complexes were converted to the Dawson 1:2-type complexes [M(α₂-P₂W₁₇O₆₁)₂]¹⁶⁻ (M = Hf, Zr), or vice versa, in solution under appropriate conditions. Also, the Dawson 2:2-type complex can be reversibly converted to the 1:1-type complex under the pH-dependent conditions. The Dawson 2:2-type POMs 1 and 2 can be compared with the recently reported, Keggin 2:2-type POMs, i.e., [M₂(μ-OH)₂(H₂O)₂]⁶⁺ (M = Hf, Zr) complexes sandwiched between 2 mono-lacunary α-Keggin POM ligands.     

The effect of ellagic acid on caspase-3/bcl-2/Nrf-2/NF-kB/TNF-α /COX-2 gene expression product apoptosis pathway: a new approach for muscle damage therapy

Molecular Biology Reports - The goal of this study was to determine the protective role of ellagic acid (EA) against CCl4-induced muscle injury in rats. In this study, 36 Wistar albino rats...     

Hyponitrite complexes: Crystal and molecular structure of [Ru2(CO)4(μ-PBu2)(μ-Ph2PCH2PPh2)(μ-η-ONNOMe)]

The new trans-hyponitrite derivative complex [Ru₂(CO)₄(μ-P^tBu₂)(μ-dppm)(μ-η²-ONNOMe)] (2, dppm = Ph₂PCH₂PPh₂) was prepared by deprotonation of [Ru₂(CO)₄(μ-H)(μ-P^tBu₂)(μ-dppm)(μ-η²-ONNOMe)][BF₄] (1) with the base DBU (1.8-diazabicyclo[5.4.0]undec-7-ene). The latter complex salt has been obtained in an improved synthesis starting from the trans-hyponitrite complex [Ru₂(CO)₄(μ-H)(μ-P^tBu₂)(μ-dppm)(μ-η²-ONNO)]. Compound 2 has been characterized by spectroscopic methods as well as by X-ray diffraction and represents the first neutral complex bearing a deprotonated monoester of the hyponitrous acid as the bridging ligand.     

综述:2型糖尿病与轻度认知障碍

阿尔茨海默病(Alzheimer's disease,AD)是一个连续的病理生理过程,包括轻度认知障碍前期(pre-MCI)、轻度认知障碍期(mild cognitive impairment,MCI)和痴呆期．AD临床期病程不可逆转,因此,pre-MCI和MCI的早期发现和干预就成为延缓和逆转AD发生的重要环节．大量研究表明,2型糖尿病(T2DM)胰岛素抵抗是导致MCI和AD的独立危险因素,T2DM与AD及AD前期认知功能障碍有密切关系．本文重点综述2型糖尿病与MCI及AD之间的相关性,探讨2型糖尿病治疗对AD的发生进行有效干预的可能性,为AD早期发现和临床治疗提供新线索．     

Folding and Fibrillogenesis: Clues from β2-Microglobulin

Renal failure impairs the clearance of β₂-microglobulin from the serum, with the result that this protein accumulates in joints under the form of amyloid fibrils. While the molecular mechanism leading to deposition of amyloid in vivo is not totally understood, some organic compounds, such as trifluoroethanol (TFE), are commonly used to promote the elongation of amyloid fibrils in vitro. This article gives some insights into the structural properties and the conformational states of β₂-microglobulin in the presence of TFE, using both the wild-type protein and the mutant Trp60Gly. The structure of the native state of the protein is rather insensitive to the presence of the alcohol, but the stability of this state is lowered in comparison to some other conformational states. In particular, a native-like folding intermediate is observed in the presence of moderate concentrations of TFE. Instead, at higher concentrations of the alcohol, the population of a disordered native-unlike state is dominant and correlates with the ability to elongate fibrils.     

Synthesis and reactions of 1′,2:4,6-di-o-isopropylidene-sucrose

The reaction of sucrose with a combination of 2,2-dimethoxypropane, N,N-dimethylformamide, and toluene-p-sulphonic acid (reagent A) gave, after acetylation followed by chromatography, 1′,2:4,6-di-O-isopropylidenesucrose tetra-acetate (1) in 15% yield. The structure of 1 was determined on the basis of p.m.r. and mass spectrometry, and by chemical transformations. Treatment of 1 with aqueous acetic acid afforded sucrose 3,3′,4′,6′-tetra-acetate 2. Reacetalation of 2 using reagent A gave 1 in 80% yield. The p.m.r. spectrum of 2 confirmed the presence of hydroxyl groups at C-2 and C-4. The following sequence of reactions showed that the remaining two hydroxyl groups were located at C-6 and C-1′. Selective tritylation of 2 gave 1′,6-di-O-tritylsucrose 3,3′,4′,6′-tetra-acetate (3) as the minor, and 6-O-tritylsucrose 3,3′,4′,6′-tetra-acetate (4) as the major, product. When tritylation was carried out under forcing conditions, 2 gave 3 as the major product. Acetylation of 4 afforded 6-O-tritylsucrose hepta-acetate. Mesylation of 2 gave the tetramethanesulphonate 5, which afforded the 6-dcoxy-6-iodo derivative 6 on treatment with a refluxing solution of sodium iodide in butanone. Treatment of 3 with methanesulphonyl chloride in pyridine gave the disulphonate 7, which on detritylation followed by acetylation gave 2,4-di-O-methanesulphonylsucrose hexa-acetate (9). Treatment of 9 with sodium benzoate in hexamethylphosphoric triamide displaced the 4-sulphonate, with inversion of configuration, to give the galacto derivative 10.     

The Aurora-A/TPX2 complex: A novel oncogenic holoenzyme?

The Aurora-A kinase regulates cell division by phosphorylating multiple downstream targets in the mitotic apparatus. Aurora-A is frequently overexpressed in tumor cells and it is therefore regarded as a novel candidate target in anti-cancer therapy. Its actual contribution to cell transformation, however, is not entirely clarified; furthermore, its transforming ability has been found to vary broadly depending on the systems and experimental conditions in which it was assayed. This variability suggests that Aurora-A overexpression requires the concomitant deregulation of partner factor(s) to fully elicit its oncogenic potential. Molecular and structural studies indicate that the full activation and correct mitotic localisation of Aurora-A require its interaction with the spindle regulator TPX2. In this review we propose a brief reappraisal of Aurora-A intrinsic oncogenic features. We then present literature screening data indicating that TPX2 is also overexpressed in many tumor types, and, furthermore, that Aurora-A and TPX2 are frequently co-overexpressed. We therefore propose that the association of Aurora-A and TPX2 gives rise to a novel functional unit with oncogenic properties. We also suggest that some of the roles that are conventionally attributed to Aurora-A in cell transformation and tumorigenesis could in fact be a consequence of the oncogenic activation of this unit.     

TXA2/PGI2与心血管疾病

血栓素(Thromboxane,TXA2)和前列环素(Prostacyclin,PGI2)均为花生四烯酸的代谢物,是前列腺素(Prostaglandins,PGs)中生物活性最强的一对。在正常情况下,二者在体内保持一定的平衡,相互拮抗、相互协调,共同维持血液循环畅通,与心血管疾病关系密切。本文即就其生物特性及与心血管病的关系等进行综述,对人们全面认识TXA2/PGI2具有一定的参考价值。     

重组腺相关病毒2型/人肿瘤坏死因子受体:Fc(rAAV2/hTNFR:Fc)的构建和生物学活性研究

为研究腺相关病毒2型载体应用于类风湿性关节炎进行基因治疗的可行性,首先构建携带人肿瘤坏死因子Ⅱ型受体胞外区和人免疫球蛋白IgG1Fc段融合基因的重组2型腺相关病毒(rAAV2／hTNFR：Fc),并对其生物学活性进行研究。以RT—PCR分别从U937和人淋巴细胞总RNA中扩增人肿瘤坏死因子Ⅱ型受体胞外区和人免疫球蛋白IgG1Fc段基因,并以重叠延伸PCR的方法将二者融合后克隆入pSNAV1载体质粒进行重组病毒生产,在进行重组病毒理化分析后,以TNFa细胞毒中和试验来研究该重组病毒的生物学活性。结果显示：所构建的重组病毒rAAV2／hTNFR：Fc基因结构与预期一致;病毒在体外感染BHK-21细胞后,含TNFR：Fc融合蛋白的表达上清可以有效中和人、大鼠、小鼠TNFα对L929的细胞毒性。所研究构建的重组腺相关病毒可以用来作为阻断TNFα的手段,进行类风湿性关节炎的基因治疗研究。     

On the Existence of a Possible A2A-D2-β-Arrestin2 Complex: A2A Agonist Modulation of D2 Agonist-Induced β-Arrestin2 Recruitment

Given that coactivation of adenosine A_2A (A_2AR) and dopamine D₂ (D₂R) receptors results in the coaggregation, cointernalization, and codesensitization of the A_2AR and D₂R and the role of scaffolding protein β-arrestin2 in the desensitization, internalization, and signaling of G-protein-coupled receptors, in this study we explored the ability of the A_2AR agonist CGS21680 in A_2AR-D₂R-coexpressing cells to modulate the D₂R agonist-induced recruitment of β-arrestin2 to the D₂R by means of proximity-based bioluminescence resonance energy transfer (BRET²) and co-trafficking analysis. We found evidence that CGS21680 can increase the maximal BRET² signal between β-arrestin2^RLuc and D_2LR^GFP2 upon D₂R activation, by increasing the potency of the D₂R agonist to exert this action. In addition, this change was associated with an increased formation of cytoplasmic clusters containing β-arrestin2^GFP2 and D_2LR^YFP as seen from the co-trafficking analysis. Furthermore, the A_2AR agonist advanced the time for the increase in Akt phosphorylation obtained with the D₂R agonist. Finally, using a novel bioinformatics approach to predict the protein-protein interface, we have also found that amino acid pro-triplets TNY, LLS, RAF, and VSR may be crucial for the -induced β-arrestin2 recruitment by A_2AR-D₂R heteromers. Taken together, the results indicate that the antagonistic A_2AR-D₂R allosteric receptor-receptor interaction in A_2AR-D₂R heteromers favors β-arrestin2 recruitment to the D_2LR protomer with subsequent cointernalization associated with a reduced time onset of Akt phosphorylation followed by a rapid dephosphorylation. Thus, β-arrestin2 action becomes more rapid and short-lasting and, in this way, mimics G-protein-mediated signaling.     

Synthesis and structural characterization of the molecular loop [cis-Mo2(N,N-di-p-anisylformamidinate)2]2(O2C-CHCCH-CO2)2

A new molecular loop composed of two quadruply bonded Mo₂(DAniF)₂ units (DAniF=N,N^′-di-p-anisylformamidinate) linked by two chiral allene-1,3-dicarboxylate anions has been prepared from the reaction of [cis-Mo₂(DAniF)₂(MeCN)₄](BF₄)₂ with the bis(tetraethylammonium) salt of allene-1,3-dicarboxylic acid. This compound, [cis-Mo₂(DAniF)₂]₂(O₂C-CHCCH-CO₂)₂ (1), has been characterized by X-ray crystallography and by ¹H NMR and UV-Vis spectroscopy. The molecule possesses a center of inversion and hence is meso. There is only weak electronic coupling between the two Mo₂ ⁴⁺ units as revealed by electrochemical measurements.     

O2 and H2O are each the source of one O in NO−2 produced from NH3 by Nitrosomonas: 15N-NMR evidence

The exchange of ¹⁸O between H₂¹⁸O and exogeneously added ¹⁵N¹⁶O^?₂ which occurs during oxidation of ammonia by Nitrosomonas is shown to occur one oxygen at a time. Conditions in which the exchange is diminished (notably the presence of ¹⁴NO^–₂ and CCCP) allowed demonstration that water and dioxygen are each the source of one oxygen in nitrite produced from ¹⁵NH₃. The nitrate produced in the presence of ¹⁸O₂ consisted of 67 and 0% ¹⁵N¹⁸O¹⁶O^? and ¹⁵N¹⁸O¹⁸O^?, respectively. Analysis was made using the ¹⁸O-isotope shift in ¹⁵N-NMR.     

1,3-Bis(α-aminoisopropyl)benzene, meta-C6H4(CMe2NH2)2: An N,N-bridging and N,C,N-cyclometalating ligand

Saponification of the bis(carbamic acid ester) 1,3-C₆H₄(CMe₂NHCO₂Me)₂ (1), made by the addition of methanol to commercial 1,3-C₆H₄(CMe₂NCO)₂, yielded the meta-phenylene-based bis(tertiary carbinamine) 1,3-C₆H₄(CMe₂NH₂)₂ (2). Dinuclear [{(η⁴-1,5-C₈H₁₂)RhCl}₂{μ-1,3-C₆H₄(CMe₂NH₂)₂}] (3) resulted from the action of 2 on [{(η⁴-1,5-C₈H₁₂)Rh(μ-Cl)}₂] in toluene. Combination of 2 with PdCl₂ or K₂[PdCl₄] gave the dipalladium macrocycle trans,trans-[{μ-1,3-C₆H₄(CMe₂NH₂)₂}₂(PdCl₂)₂] (4) along with cyclometalated [{2,6-C₆H₃(CMe₂NH₂)₂-κN,κC¹,κN′}PdCl] (5). Substitution of PEt₃ for the labile chlorido ligand of 5 afforded [{2,6-C₆H₃(CMe₂NH₂)₂-κN,κC¹, κN′}Pd(PEt₃)]Cl (6). The crystal structures of the following compounds were determined: bis(carbamic acid ester) 1, ligand 2 as its bis(trifluoroacetate) salt [1,3-C₆H₄(CMe₂NH₃)₂](O₂CCF₃)₂, 2 · (HAc_f)₂, complexes 3 and 6, as well as 1,3-C₆H₄(CMe₂OH)₂ (the diol analogue of 2).     

CCN2/decorin interactions: a novel approach to combating fibrosis?

CCN2 (connective tissue growth factor, CTGF), a member of the CCN family is overexpressed in fibrotic disease and is essential for the development of experimental fibrosis. Drugs targeting CCN2 action may therefore prove to be useful anti-fibrotic approaches. CCN2 acts via integrins and heparan sulfate-containing proteoglycans (HSPGs). In a recent study, Vial and colleagues (2011) show that decorin can bind CCN2. A peptide corresponding to the leucine rich repeats peptide 12 region of decorin can neutralize CCN2-mediated activity on C2C12 cells in vitro. Thus it is conceivable that this peptide could be used in the future as a novel antifibrotic approach.     

TAB2/TAB3:炎症激活和调控的重要组件

TAK1结合蛋白2(TAK1 binding protein 2,TAB2)和TAK1结合蛋白3(TAK1 binding protein 3,TAB3)是转化生长因子β活化激酶1(transforming growth factor-β-activated kinase 1,TAK1)结合蛋白(TAK1 binding proteins,TABs)的两种同源蛋白,它们作为TAK1-TABs复合物的关键组成部分可介导激活丝裂原活化蛋白激酶(mitogen-activated protein kinase,MAPK)和核因子κB(nuclear factor kappa-B,NF-κB)信号级联,促进炎症反应的发生,并且TAB2/TAB3的表达水平及其翻译后修饰对炎症调控意义非凡,该文主要对上述过程中TAB2/TAB3的作用进行简述。     

The reactions of 2-hydroxypyridine ligands with Re2Cl4(μ-dppm)2 (dppm=Ph2PCH2PPh2) that lead to 2-pyridonate complexes

2-Hydroxypyridine (Hhp), 2-hydroxynicotinic acid (HnicOH) and 6-hydroxypicolinic acid (HpicOH) react with Re₂Cl₄(μ-dppm)₂ (dppm=Ph₂PCH₂PPh₂) to afford the complexes Re₂(η²-hp)Cl₃(μ-dppm)₂ (1), Re₂(η²-HnicO)Cl₃(μ-dppm)₂ (2) and Re₂(μ-picO)₂(μ-dppm)₂ (3). The identities of 1 and 2 have been established by single-crystal X-ray structure determinations (Re-Re distances of 2.2602(3) and 2.2539(3) Å, respectively) and they are shown to have unsymmetrical structures with staggered rotational geometries and trans, cis coordination of the pair of μ-dppm ligands. The crystal of 2 that was used in the structure determination was found to be of composition 2Re₂(η²-HnicO)Cl₃(μ-dppm)₂ · Re₂Cl₆(μ-dppm)₂ · 2.906CH₂Cl₂. The structure of Re₂Cl₆(μ-dppm)₂ in this crystal is compared with structures reported in the literature for other crystals that contain this edge-sharing bioctahedral dirhenium(III) complex.     

Molecular structure of tetranuclear [{Mo2O(S2CNEt2)(η-O2CCF3)(μ-N-o-tol)2}2(μ-O)(μ-O2CCF3)2] formed upon addition of trifluoroacetic acid to syn-[MoO(μ-N-o-tol)(S2CNEt2)]2

Addition of trifluoroacetic acid to syn-[MoO(μ-N-o-tol)(S₂CNEt₂)]₂ in chloroform affords tetranuclear [{Mo₂O(S₂CNEt₂)(η¹-O₂CCF₃)(μ-N-o-tol)₂}₂(μ-O)(μ-O₂CCF₃)₂] which has been crystallographically characterised. It consists of four molybdenum(V) centres linked via bridging imido, trifluoroacetate and oxo ligands and results from replacement of a dithiocarbamate by two trifluoroacetate ligands.     

Mdm2/MdmX抑制剂

Mdm2(murine double minute 2,又称为Hdm2)和Mdm X(murine double minute X,又称为Hdm4)的异常过表达与近半数的癌症直接相关,设计靶向Mdm2/Mdm X-p53蛋白质相互作用位点抑制剂,解除Mdm2和Mdm X对p53的抑制作用有着重要的临床意义。尽管Mdm2和MdmX结构非常相似,但仅有Mdm2小分子抑制剂的筛选和设计研究较深入。对依据nutlin分子构效关系、结构生物学、组合化学多重优化等手段筛设计MdmX抑制剂的研究进展进行简述,并讨论天然产物库在筛选Mdm X/Mdm2抑制剂新型结构框架的应用前景。